Home/ORCA Therapeutics/Wenliang Dong
WD

Wenliang Dong

CEO

ORCA Therapeutics

Therapeutic Areas

ORCA Therapeutics Pipeline

DrugIndicationPhase
ORCA-010Localized Prostate CancerPhase I/IIa